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OBJECTIVEdStroke symptoms among individuals reporting no physician diagnosis of stroke
are associated with an increased risk of future stroke. Few studies have assessed whether indi-
viduals with diabetes or prediabetes, but no physician diagnosis of stroke, have an increased
prevalence of stroke symptoms.
RESEARCH DESIGN ANDMETHODSdThis study included 25,696 individuals aged
$45 years from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
who reported no history of stroke or transient ischemic attack at baseline (2003–2007). Glucose
measurements, medication use, and self-reported physician diagnosis were used to categorize
participants into diabetes, prediabetes, or normal glycemia groups. The presence of six stroke
symptoms was assessed using a validated questionnaire.
RESULTSdThe prevalence of any stroke symptom was higher among participants with
diabetes (22.7%) compared with those with prediabetes (15.6%) or normal glycemia
(14.9%). In multivariable models, diabetes was associated with any stroke symptom (prev-
alence odds ratio [POR] 1.28 [95% CI 1.18–1.39]) and two or more stroke symptoms (1.26
[1.12–1.43]) compared with normal glycemia. In analyses of individual stroke symptoms,
diabetes was associated with numbness (1.15 [1.03–1.29]), vision loss (1.52 [1.31–1.76]),
half-vision loss (1.54 [1.30–1.84]), and lost ability to understand people (1.34 [1.12–1.61])
after multivariable adjustment. No association was present between prediabetes and stroke
symptoms.
CONCLUSIONSdIn this population-based study, almost one in four individuals with di-
abetes reported stroke symptoms, which suggests that screening for stroke symptoms in diabetes
may be warranted.
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More than 40% of adults in the U.S.have diabetes or prediabetes (1),which increases the risk of micro-
vascular and macrovascular complications,
including stroke. In a recent meta-analysis
of 102 epidemiologic studies, adults with
diabetes were two to three times as likely as
adults without diabetes to have an ischemic
stroke (2). Additionally, diabetes has been
associated with an increased risk of various
ischemic stroke subtypes, including lacu-
nar and thrombotic stroke (3,4), while
weaker associations have been reported
for diabetes and hemorrhagic stroke (2).
In contrast, inconsistent ﬁndings have
been reported for the association between
prediabetes and stroke. Several studies
have reported an association between pre-
diabetes and ischemic stroke (5–8), while
others have reported no association (9,10).
Although individuals with diabetes
have an increased risk of stroke, not all
strokes come to clinical attention. In the
general population, stroke symptoms
among individuals reporting no history
of a stroke diagnosis have been associated
with an increased risk of future stroke, sug-
gesting that at least some reported stroke
symptoms may be indicative of clinically
unrecognized strokes (11–14). However,
few studies have examined the association
between prediabetes or diabetes and stroke
symptoms. If individuals with prediabetes
and diabetes have an increased prevalence
of stroke symptoms without a stroke diag-
nosis, screening this population for stroke
symptoms may be warranted and used to
guide clinicalmanagement programs for the
prevention of stroke. The purpose of this
study was to evaluate the association of pre-
diabetes and diabetes with the prevalence of
stroke symptoms in a large national study of
U.S. adults aged $45 years without a his-
tory of stroke or transient ischemic attack
(TIA).Additionally, the associationbetween
metabolic syndrome and stroke symptoms
among participants without diabetes was
investigated in a secondary analysis.
RESEARCH DESIGN AND
METHODSdThe current study is a
cross-sectional analysis of baseline data
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from the REasons for Geographic And
Racial Differences in Stroke (REGARDS)
study. TheREGARDS study is a prospective,
population-based cohort study designed
to investigate racial and geographic dif-
ferences in stroke incidence and stroke
mortality. Details of the study objectives and
design have previously been published (15).
In brief, 30,239 African American and
white adults aged$45 years were enrolled
between 2003 and 2007, with 56% of par-
ticipants recruited from the “stroke buckle”
(deﬁned as the coastal North Carolina,
South Carolina, and Georgia areas) and
“stroke belt” (the remainder of North
Carolina, South Carolina, and Georgia as
well as Alabama, Mississippi, Tennessee,
Arkansas, and Louisiana) regions and the
remaining 44% of participants recruited
from the other 40 contiguous U.S. states
and theDistrict of Columbia. TheREGARDS
study protocol was approved by the in-
stitutional review boards of each partici-
pating institution, and all participants
provided written informed consent.
Individuals reporting a history of stroke
or TIA at baseline (n = 3,033), missing data
on stroke or TIA history (n = 279), missing
data on stroke symptoms (n = 376), and
missing data on glucose level or oral diabe-
tes medications (n = 855) were excluded
from this study, resulting in 25,696 partic-
ipants in this cross-sectional analysis.
Data collection and variables
Structured telephone interviews, self-
administered questionnaires, and in-home
examinations were used to assess demo-
graphic, lifestyle, and clinical factors at
baseline. Age, sex, race, education, annual
household income, health insurance,
smoking status, alcohol consumption, and
current use of insulin, oral diabetes, and
antihypertensive medications were self-
reported. Participants were asked up to
two questions about alcohol consumption
during the telephone interview: 1) “Do
you presently drink alcoholic beverages,
including beer, wine, and other drinks
made with hard liquor, even occasion-
ally?” and if the response was yes, then
2) “How many alcohol beverages do you
presently drink?” Moderate alcohol con-
sumption was deﬁned as one drink daily
or less for women and two drinks daily or
less for men, and heavy alcohol consump-
tion was deﬁned as more than one drink
daily for women and more than two
drinks daily for men based on federal di-
etary guidelines (16). Geographic region
(stroke buckle, stroke belt, and other)
and urban/rural residence (urban, rural,
and mixed) was determined using partic-
ipant address and census data. During the
in-home examination, blood pressure,
height, and weight were measured fol-
lowing a standardized protocol. In brief,
after the participant had been sitting for
several minutes, two seated systolic and
diastolic blood pressure measurements
were taken by a trained technician using
an aneroid sphygmomanometer (American
Diagnostic Corporation, Hauppauge, NY)
that was regularly evaluated for quality
control (17). Blood pressures were taken
following a standardized protocol in the
left arm of participants and using a large-
size cuff if the participant’s arm circumfer-
ence exceeded 13 inches. The average of
the two blood pressure measurements was
used in this analysis. BMIwas calculated as
weight in kilograms divided by the square
of height in meters. An electrocardiogram
was also recorded during the in-home ex-
amination and analyzed at a central read-
ing center to determine the presence of
atrial ﬁbrillation, myocardial infarction,
and left ventricular hypertrophy (LVH).
Atrial ﬁbrillation and prior myocardial in-
farctionwere deﬁnedusingMinnesota code
criteria (18), and LVH was deﬁned using
sex-speciﬁc Cornell voltage cut points
(19). History of coronary heart disease
was deﬁned as myocardial infarction on
electrocardiogram, self-reported myocar-
dial infarction, or prior coronary revascu-
larization procedures. Blood samples were
collected during the in-home examination
following standardized protocols and were
analyzed at a central laboratory. Serum glu-
cose was measured using colorimetric re-
ﬂectance spectrophotometry on the Ortho
Vitros 950 IRCClinical Analyzer (Johnson&
Johnson Clinical Diagnostics) with a coef-
ﬁcient of variation of 1%.
Diabetes, prediabetes, and
metabolic syndrome
Diabetes was deﬁned as a fasting serum
glucose $126 mg/dL ($7 mmol/L) (20)
(or a random serum glucose$200 mg/dL
[$11.1 mmol/L] for the 13% of partici-
pants who did not fast for a minimum of
8 h), current use of insulin or oral diabetes
medications, or a self-reported physician
diagnosis of diabetes while not pregnant.
Prediabetes was deﬁned as a fasting serum
glucose between 100 and 125 mg/dL (5.6
and,7 mmol/L) (20) or a random serum
glucose between 140 and 199 mg/dL (7.8
and ,11.1 mmol/L) among participants
not using insulin or oral diabetes medica-
tions and without a history of diabetes.
Normal glycemia was deﬁned as a fasting
serumglucose,100mg/dL (,5.6mmol/L),
a random serum glucose ,140 mg/dL
(,7.8 mmol/L), no use of insulin or oral
diabetes medications, and no history of
diabetes. Metabolic syndrome was calcu-
lated only among participants without di-
abetes and who fasted overnight prior to
the REGARDS study visit (n = 17,054).
Metabolic syndrome was deﬁned based
on having three or more of the following
components: 1) systolic blood pressure
$130 mmHg, diastolic blood pressure
$85 mmHg, or current antihypertensive
medication use; 2) HDL cholesterol ,40
mg/dL in men and,50 mg/dL in women;
3) triglycerides $150 mg/dL; 4) fasting
glucose $100 mg/dL; and 5) waist cir-
cumference .102 cm in men and .88
cm in women (21).
Stroke symptoms
Stroke symptoms were assessed during
the baseline telephone interview using the
Questionnaire for Verifying Stroke-Free
Status (QVSS), a validated questionnaire
(22,23) consisting of eight questions de-
signed to identify stroke-free individuals
in the general population (24). The ﬁrst
two questions inquire about a physician
diagnosis of stroke or TIA, and the remain-
ing six questions (Supplementary Table 1)
inquire about the sudden onset of each of
six stroke symptoms: weakness (unilateral),
numbness (unilateral), vision loss in one or
both eyes, half-vision loss, lost ability to un-
derstand people, and lost ability to express
self verbally or inwriting.We reported good
sensitivity (82%) and reasonable speciﬁcity
(62%) for a positive response to any of the
stroke symptoms comparedwith a neurol-
ogist diagnosis of stroke or TIA (25).
The association of diabetes status
with stroke symptoms was evaluated
using the following classiﬁcation: 1) any
of the six stroke symptoms, 2) each stroke
symptom individually, 3) two or more of
the six stroke symptoms, and 4) speciﬁc
stroke symptom clusters that are similar
to common clinical presentations (25).
The stroke symptom clusters evaluated
were as follows: 1) weakness (unilateral)
and numbness (unilateral), 2) lost ability
to understand people and lost ability to
express oneself verbally or in writing, and
3) weakness (unilateral) and lost ability to
express oneself verbally or in writing.
Statistical analysis
Participant characteristics were calculated
by diabetes category (i.e., diabetes, pre-
diabetes, and normal glycemia). Logistic
regression was used to calculate prevalence
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odds ratios (PORs) (95% CI) for the asso-
ciation of diabetes, prediabetes, and stroke
symptoms, using normal glycemia as the
reference group. Initial models included
adjustment for age, race, and sex. Sub-
sequent models included additional ad-
justment for education, annual household
income, health insurance, geographic re-
gion, urban/rural residence, systolic blood
pressure, antihypertensive medication use,
smoking status, alcohol consumption,
BMI, atrial ﬁbrillation, LVH, and history
of coronary heart disease. A secondary
analysis was also performed to evaluate
the association between metabolic syn-
drome and stroke symptoms. Effect mod-
iﬁcation by age, race, sex, and geographic
region was evaluated in fully adjusted
models using interaction terms. Multiple
imputation with ﬁve datasets (26) was
used to obtain values for 19% of partici-
pants who were missing data on covari-
ates. The most commonly missing
covariate was income. All analyses were





Participant characteristics are presented
in Table 1 by diabetes category. Overall,
23.6% of participants had diabetes,
15.6% had prediabetes, and 60.8% had
normal glycemia. Each participant char-
acteristic investigated was associated with
diabetes status except health insurance
and current smoking.
Participants with diabetes had the
highest prevalence of any stroke symp-
tom (22.7%) followed by participants
with prediabetes (15.6%) or normal gly-
cemia (14.9%). They also had a higher
prevalence of each stroke symptom com-
pared with individuals with prediabetes
or normal glycemia (Fig. 1). Participants
with diabetes were more likely to report
any stroke symptom after adjustment for
age, race, and sex (POR 1.56 [95% CI
1.45–1.69) and in a fully adjusted model
(1.28 [1.18–1.39]). Additionally, diabe-
tes was associated with each stroke symp-
tom individually after adjustment for age,
race, and sex, but the associations re-
mained statistically signiﬁcant after mul-
tivariable adjustment only for numbness
onone side, vision loss, half-vision loss, and
lost ability to understand people (Table 2).
Prediabetes was not associated with hav-
ing any of the six stroke symptoms in
crude or adjusted models. Differences in
the association of diabetes and stroke
symptoms were investigated by age, race,
sex, and geographic region, but none were
statistically signiﬁcant (P . 0.10).
The prevalence of stroke symptom
clusters is presented in Fig. 2. Participants
with diabetes had a higher prevalence of
any two or more stroke symptoms (9.6%)
compared with participants with prediabe-
tes (5.8%) or normal glycemia (5.7%). The
prevalence of stroke symptom clusters was
also higher among participants with diabe-
tes compared with those with prediabetes
or normal glycemia. After multivariable ad-
justment, participants with diabetes were
more likely to have two or more stroke
symptoms (Table 2) compared with those
with normal glycemia. Diabetes was also
associated with stroke symptom clusters
after adjustment for age, race, and sex,
but these associations were attenuated
and no longer statistically signiﬁcant after
additional multivariable adjustment. Predi-
abetes was not associated with having two




Among participants without diabetes,
29.2% had metabolic syndrome. Among
those with metabolic syndrome, 87.9%
had elevated blood pressure, 79.6% had
abdominal obesity, 68.5% had low HDL
cholesterol, 57.9% had elevated triglycer-
ides, and 51.6% had elevated glucose.
Metabolic syndrome was associated with
any stroke symptom (POR 1.13 [95% CI
1.03–1.24]) and with sudden weakness
and sudden numbness individually after
multivariable adjustment (Supplemen-
tary Table 2). Additionally, metabolic
syndrome was associated with having
two or more stroke symptoms (1.26
[1.10–1.44]) and the cluster of unilateral
weakness and numbness (1.41 [1.17–
1.71]) after adjustment for age, race, and
sex, but both of these associations were
Table 1dCharacteristics of the REGARDS study participants by diabetes status
Normal glycemia Prediabetes Diabetes P
n 15,615 4,011 6,070
Age (years) 64.0 (9.5) 64.2 (9.1) 65.3 (8.8) ,0.001
Women 56.6 51.0 53.0 ,0.001
African American 34.7 40.6 55.5 ,0.001
Geographic region
Other 45.8 41.8 41.8 Ref.
Stroke belt 34.3 35.8 35.6 ,0.001
Stroke buckle 20.0 22.4 22.6 ,0.001
Urban/rural residence
Urban 69.5 71.5 72.4 Ref.
Rural 20.3 18.4 18.1 ,0.001
Mixed 10.2 10.1 9.4 0.024
High school education 90.7 89.7 81.8 ,0.001
Annual household income (USD)
,20,000 16.4 17.5 27.2 Ref.
20,000–34,999 26.0 25.0 30.6 ,0.001
35,000–74,999 35.9 37.3 30.7 ,0.001
$75,000 21.8 20.3 11.5 ,0.001
Health insurance 93.5 92.6 92.9 0.101
Current smoking 14.0 15.3 13.8 0.829
Alcohol consumption
None 57.7 59.0 72.6 Ref.
Moderate 37.7 35.4 25.3 ,0.001
Heavy 4.6 5.6 2.2 ,0.001
BMI (kg/m2) 28.0 (5.6) 30.4 (6.0) 32.1 (6.6) ,0.001
Systolic blood pressure (mmHg) 125.2 (16.0) 129.3 (16.2) 130.9 (16.8) ,0.001
Antihypertensive medication use† 60.7 64.4 82.0 ,0.001
Statin use 23.9 30.3 44.7 ,0.001
Atrial ﬁbrillation 7.1 8.0 9.6 ,0.001
Left ventricular hypertrophy 4.5 5.1 7.5 ,0.001
History of coronary heart disease 12.9 15.5 23.5 ,0.001
Data are means (SD) or percent. †Among individuals with hypertension.
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attenuated and not statistically signiﬁcant
after multivariable adjustment (Supple-
mentary Table 3).
CONCLUSIONSdIn this population-
based study of middle-aged and older
adults, almost one in four individuals
with diabetes but without a physician
diagnosis of stroke had experienced
stroke symptoms. Diabetes was associ-
ated with both individual stroke symp-
toms and multiple stroke symptoms.
Because diabetes heightens the risk for
vascular complications, the association
between diabetes and stroke symptoms
observed in this study among those
without a reported stroke diagnosis could
reﬂect a high prevalence of unrecognized
strokes. Prediabetes was not associated
with any stroke symptom or two or more
stroke symptoms. However, metabolic syn-
drome was associated with the occurrence
of any stroke symptom but not two ormore
stroke symptoms.
The association between diabetes and
stroke symptoms has been investigated in
previous studies. In the Atherosclerosis
Risk in Communities (ARIC) study of
middle-aged white and African American
adults, diabetes was associated with
stroke symptoms in each race-sex group
after adjustment for age and study site,
but additional multivariable adjustment
was not reported and individuals with a
prior history of stroke were not excluded
(27). Another study of middle-aged
adults in Scotland that did exclude those
with a history of stroke reported that men
with diabetes were more likely to report
two or more stroke symptoms, while no
difference in stroke symptomswas reported
among women (12). The current study
found that both men and women with di-
abetes were more likely to report any
stroke symptom and two or more stroke
symptoms even though they reported no
stroke diagnosis and that these associa-
tions persisted after multivariable adjust-
ment. The prior studies used different
questionnaires and assessed different
stroke symptoms than the current study
but suggest that our ﬁnding of a 50%
greater prevalence of stroke symptoms
among individuals with diabetes warrants
further investigation of the occurrence of
clinically unrecognized strokes in this
high-risk population.
Prediabetes was not associated with
individual stroke symptoms or clusters of
stroke symptoms among the individuals
without a reported stroke diagnosis in the
current study. Few data have been pub-
lished on the association between pre-
diabetes and stroke symptoms without
a stroke diagnosis. In prior studies, the
association between prediabetes and
Figure 1dPrevalence of any stroke symptom and each individual stroke symptom by diabetes status: the REGARDS study.
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cardiovascular outcomes has been weaker
than the association reported for diabetes
(28). Additionally, no association has
been reported for prediabetes and stroke
in some studies (9,10). It is possible that
some people with prediabetes may have
been misclassiﬁed in this study because
only fasting or random glucose was used
to determine prediabetes status and not
oral glucose tolerance tests or A1C. Fur-
thermore, while each of these testing
methods is acceptable for assessing pre-
diabetes status, there is considerable
discordance among their results (29), re-
ﬂecting current challenges in classifying
prediabetes.
Metabolic syndrome has been asso-
ciated with an increased risk of stroke
among individuals without diabetes (30),
but data investigating the association be-
tween metabolic syndrome and stroke
symptoms are limited. The current study
observed an association between meta-
bolic syndrome and any stroke symptom
but not two or more stroke symptoms
after multivariable adjustment. Addi-
tionally, metabolic syndrome was not
associated with the individual stroke
symptoms of vision loss and lost ability
to understand, although these symp-
toms were associated with diabetes in
this study.
It is unclear whether the stroke symp-
toms reported among people with diabe-
tes in this study represent unrecognized
cerebral infarcts speciﬁcally or some
other pathophysiologic process, possibly
related to diabetes complications (e.g.,
retinopathy, neuropathy). Brain imaging
was not available in this study; thus,
we could not conﬁrm the prevalence of
imaging-conﬁrmed strokes. It is notable
that previous studies have reportedmostly
null ﬁndings for the association between
diabetes and silent cerebral infarctions (31–
35), with the exception of the Rotterdam
Scan Study, which reported an associa-
tion between diabetes and incident silent









Model 1 1 (ref.) 1.03 (0.94–1.14) 1.56 (1.45–1.69)***†††
Model 2 1 (ref.) 0.98 (0.89–1.08) 1.28 (1.18–1.39)***†††
Individual stroke symptoms
Sudden weakness, unilateral
Model 1 1 (ref.) 0.97 (0.82–1.14) 1.49 (1.32–1.68)***†††
Model 2 1 (ref.) 0.88 (0.75–1.04) 1.10 (0.97–1.26)†
Sudden numbness, unilateral
Model 1 1 (ref.) 1.13 (0.99–1.29) 1.47 (1.32–1.63)***†††
Model 2 1 (ref.) 1.04 (0.91–1.19) 1.15 (1.03–1.29)*
Sudden painless loss of vision in one or both eyes
Model 1 1 (ref.) 1.11 (0.93–1.32) 1.73 (1.51–1.98)***†††
Model 2 1 (ref.) 1.09 (0.91–1.31) 1.52 (1.31–1.76)***†††
Sudden loss of half-vision
Model 1 1 (ref.) 0.93 (0.74–1.17) 1.71 (1.45–2.02)***†††
Model 2 1 (ref.) 0.94 (0.74–1.19) 1.54 (1.30–1.84)***†††
Suddenly lost ability to understand people
Model 1 1 (ref.) 1.00 (0.79–1.27) 1.72 (1.45–2.04)***†††
Model 2 1 (ref.) 0.98 (0.77–1.25) 1.34 (1.12–1.61)**†
Suddenly lost ability to express self verbally or in writing
Model 1 1 (ref.) 0.85 (0.69–1.04) 1.36 (1.17–1.59)***†††
Model 2 1 (ref.) 0.81 (0.65–1.00) 1.10 (0.93–1.29)††
Any 2 or more stroke symptoms
Model 1 1 (ref.) 1.00 (0.86–1.17) 1.63 (1.46–1.83)***†††
Model 2 1 (ref.) 0.94 (0.81–1.10) 1.26 (1.12–1.43)***†††
Stroke symptom clusters
Weakness (unilateral) plus numbness (unilateral)
Model 1 1 (ref.) 1.08 (0.88–1.32) 1.51 (1.28–1.77)***††
Model 2 1 (ref.) 0.97 (0.78–1.19) 1.07 (0.90–1.27)
Lost understanding plus lost expression
Model 1 1 (ref.) 1.08 (0.77–1.52) 1.73 (1.34–2.23)***†
Model 2 1 (ref.) 1.04 (0.73–1.47) 1.29 (0.98–1.70)
Weakness (unilateral) plus lost expression
Model 1 1 (ref.) 0.92 (0.64–1.33) 1.46 (1.12–1.91)**†
Model 2 1 (ref.) 0.82 (0.56–1.19) 0.97 (0.73–1.30)
Model 1 adjusts for age, race, and sex. Model 2 adjusts for model 1 variables plus income, education, health insurance, geographic region, urban/rural residence,
systolic blood pressure, antihypertensive medication use, BMI, smoking status, alcohol consumption, atrial ﬁbrillation, left ventricular hypertrophy, and history of
cardiovascular disease. *P , 0.05 compared with normal glycemia. **P , 0.01 compared with normal glycemia. ***P , 0.001 compared with normal glycemia.
†P , 0.05 compared with prediabetes. ††P , 0.01 compared with prediabetes. †††P , 0.001 compared with prediabetes.
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cerebral infarctions over 3.5 years of
follow-up (36). Additionally, inconsis-
tent ﬁndings have been reported for
the association between prediabetes and
silent cerebral infarctions (37,38). The
current study focused on clinically overt
symptoms, which may or may not have
been evaluated by a physician, and the re-
lationship between these overt stroke
symptoms and truly silent cerebral in-
farcts is not clear. The QVSS used in
this study assessed the sudden onset of
unilateral numbness and weakness,
whereas diabetic neuropathy typically
does not have a sudden onset and often
presents bilaterally. Stroke symptom
clusters, which may be less prone to mis-
classiﬁcation, were also more common
among individuals with diabetes in the
current study. However, the prevalence
of stroke symptom clusters was low
overall, limiting the power of this anal-
ysis. While the QVSS has demonstrated
good sensitivity and modest speciﬁcity
compared with stroke status determined
by a neurologist in a general medicine
population (25), its performance in a
population of people with diabetes has
not been evaluated.
This study has additional potential
limitations. A history of stroke/TIA was
determined using self-reported physician
diagnosis. These questions have been
shown to be reliable (23) but are subject
to recall bias. Additionally, the classiﬁca-
tion for diabetes, prediabetes, and normal
glycemia was determined using a single
fasting or random glucose measurement
among those who did not use insulin or
oral diabetes medications and did not
report a history of diabetes. For a clinical
diagnosis of diabetes, it is recommended
that a repeat test is performed to verify a
diagnosis, but this was not available in
this study, and duration of diabetes was
not assessed either. Additionally, residual
confounding is a possibility in this analy-
sis. The REGARDS study also has several
strengths, including its large national
sample of middle-aged and older adults,
inclusion of a large sample of African
Americans who are at high risk of both
stroke and other diabetes complications,
and the collection of demographic, be-
havioral, clinical, and laboratory data
following a standardized study protocol.
In summary, in this study of individ-
uals from a large national, population-
based study who reported no diagnosis of
stroke, stroke symptoms were common
among those with diabetes, and diabetes
was independently associated with stroke
symptoms. Given that 42% of participants
Figure 2dPrevalence of two or more stroke symptoms and stroke symptom clusters by diabetes status: the REGARDS study.
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with stroke symptoms have reported not
seeking medical care for these symptoms
(39), the need for physicians to actively
query about potential stroke symptoms
and implement stroke risk reduction strat-
egies, including pharmacologic therapy
when indicated, is underscored. These
ﬁndings have implications for stroke pre-
vention efforts and suggest that screening
for stroke symptoms among individuals
with diabetes may be warranted.
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